MIT scientists find promising Alzheimer's treatment breakthrough.
MIT neuroscientists have discovered a potential treatment for Alzheimer's disease using peptides that interact with the overactive CDK5 enzyme in Alzheimer's patients' brains. The treatment has undergone animal trials and shown promising results, reducing neurodegeneration and DNA damage in the brain, reducing mutations of Tau pathologies and neuron loss, and improving behavioral deficits. The peptide was also able to penetrate the blood-brain barrier and reach the neurons in the hippocampus. Further testing will be carried out to see which forms of dementia might benefit from this treatment.